TNF Inhibitors Linked to Increased Multiple Sclerosis Risk :

In a large, retrospective cohort study, investigators found a slightly increased risk for MS in patients on TNF therapy, especially among those being treated for rheumatic disease.

Related Keywords

Ohio , United States , Canada , United Kingdom , Cleveland , Vancouver , British Columbia , British , Canadian , Amy Kunchok , Antonio Avi , Arthritis Research Canada , Cleveland Clinic Mellen Center , Medscape Medical , Medscape Medical News , Cleveland Clinic , Mellen Center , Multiple Sclerosis , Multiple Sclerosis Ms , Us , Multiple Sclerosis Risk , Ms Risk , Ultiple Sclerosis Risk Factors , S Risk Factors , Isk Of Multiple Sclerosis , Isk Of Ms , Rheumatic Disease , Plaque Psoriasis , Psoriatic Arthritis , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Arthritis , Oint Inflammation , Myelin , Psoriatic Enthesopathy , Tnf Alpha , Tumor Necrosis Factor Alpha , Umor Ne ,